This cohort study assesses the association between hormone replacement therapy exposure and invasive breast cancer diagnosis among women in Israel carrying BRCA1 and BRCA2 pathogenic variants.
JAMA Network Open published a clinical update in Research Highlights on 08 Apr 2026.
The item focuses on Hormone Therapy and Breast Cancer Risk in Women With BRCA Variant.
Review the original article for the full source wording and details.